|
Real-time Estimate
Cboe BZX
17:51:24 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 21.62 USD | +0.49% |
|
+4.00% | -18.51% |
| 09-22 | Oppenheimer Adjusts Price Target on Tyra Bioscience to $40 From $50, Keeps Outperform Rating | MT |
| 09-14 | Tyra Bioscience Shares Rise After Pricing $400 Million Offering | MT |
| Market Cap | 1.48B 1.33B 1.23B 1.11B 2.08B 141B 2.1B 14.7B 5.84B 73.67B 5.55B 5.44B 234B | P/E 2026 * |
-8.09x | P/E 2027 * | -7.76x |
|---|---|---|---|---|---|
| Enterprise Value | 989M 888M 820M 743M 1.39B 93.94B 1.41B 9.83B 3.9B 49.24B 3.71B 3.63B 156B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
97.57% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TYRA | Delayed | |
CBOE
| TYRA | Real-time |
Last Transcript: Tyra Biosciences, Inc.
| 1 day | +0.56% | ||
| 1 week | +4.00% | ||
| Current month | -2.03% | ||
| 1 month | -0.12% | ||
| 3 months | -30.62% | ||
| 6 months | -38.89% | ||
| Current year | -18.51% |
| 1 week | 20.05 |  | 21.58 |
| 1 month | 18.25 | | 22.62 |
| Current year | 18.25 | | 40.65 |
| 1 year | 13.35 | | 40.65 |
| 3 years | 6.42 | | 40.65 |
| 5 years | 4.93 | | 40.65 |
| 10 years | 4.93 | | 40.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Bensen
COO | Chief Operating Officer | 51 | 01/11/2018 |
Todd Harris
CEO | Chief Executive Officer | 46 | 01/11/2018 |
Alan Fuhrman
DFI | Director of Finance/CFO | 69 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert More
CHM | Chairman | 58 | 01/03/2019 |
Todd Harris
BRD | Director/Board Member | 46 | 02/08/2018 |
Jake Simson
BRD | Director/Board Member | 40 | 01/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/15/26 A | Free | Chief Financial Officer | 951 | 0.0014% | ||
| 9/15/26 A | Free | Founder | 864 | 0.0013% | ||
| 9/15/26 A | RA Capital Management LP
| Buy | Company | 9,078,529 | 13.2040% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.49% | +4.00% | +47.15% | +87.45% | 1.48B | |
| +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | |
| +2.96% | +2.47% | +13.14% | +84.27% | 54.55B | |
| -0.94% | +1.25% | +10.73% | +102.70% | 53.59B | |
| +3.41% | +1.06% | +28.16% | +57.80% | 44.75B | |
| +2.34% | -3.35% | +17.89% | +100.16% | 41.62B | |
| +0.86% | -3.97% | +220.72% | +916.70% | 39.91B | |
| -0.74% | -4.46% | +11.00% | +44.65% | 32.47B | |
| +25.03% | +38.17% | +93.84% | +81.82% | 26.7B | |
| +3.72% | -6.23% | +26.01% | -8.28% | 23.36B | |
| Average | +3.77% | -0.09% | +50.22% | +152.78% | 38.19B | |
| Weighted average by Cap. | +3.05% | -0.46% | +46.54% | +159.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -177M -159M -147M -133M -249M -16.85B -252M -1.76B -700M -8.83B -666M -652M -28B | -209M -188M -173M -157M -294M -19.87B -297M -2.08B -825M -10.41B -785M -768M -33.03B |
| Net Debt | -491M -440M -407M -369M -689M -46.6B -698M -4.87B -1.94B -24.43B -1.84B -1.8B -77.46B | -323M -290M -268M -243M -454M -30.67B -459M -3.21B -1.27B -16.08B -1.21B -1.19B -50.98B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | $21.43 | -0.44% | 54,692 |
| 27/10/26 | $21.52 | +5.39% | 523,034 |
| 26/10/26 | $20.42 | -0.15% | 790,340 |
| 23/10/26 | $20.45 | -2.01% | 520,381 |
| 22/10/26 | $20.87 | +1.31% | 826,147 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TYRA Stock
Select your edition
All financial news and data tailored to specific country editions
